Artificial intelligence can use physiological parameters to optimize treatment strategies and predict clinical deterioration of sepsis in ICU

Author:

Zhang Quan,Wang JianqiORCID,Liu Guohua,Zhang Wenjia

Abstract

Abstract Objective. Sepsis seriously threatens human life. Early identification of a patient’s risk status and appropriate treatment can reduce septic shock risk and mortality. Our purpose is to design and validate an adjunctive therapy system based on deep reinforcement learning (DRL), which can provide treatment recommendations with providence and assess the patient’s risk status and treatment options in the early stages. Approach. Data is from the Beth Israel Deaconess Medical Center. The raw data included 53 423 patients from MIMIC-III. Of these, 19 620 eligible samples were screened to form the final cohort. First, the patient’s physiological parameters were fed into the DRL therapy strategy recommendation module (TSRM), which provides a forward-looking recommendation for treatment strategy. The recommended strategies were then fed into the reinforcement learning risk assessment module (RAM), which predicts the patient’s risk status and treatment strategy from a long-term perspective. The DRL model designed in this paper assists in formulating treatment plans and evaluating treatment risks and patient status through continuous interaction with patient trajectory; this model therefore has the foresight that a supervising deep learning model does not. Main results. The experiment shows that, in the test set for the TSRM, mortality is the lowest when the treatment strategy that is actually implemented is the same as the AI-recommended strategy. Regarding the RAM, it can accurately grasp a patient’s deterioration trend, and can reasonably assess a patient’s risk status and treatment plans at an early stage. The assessment results of the model were matched with the actual clinical records. Significance. A DRL-based sepsis adjunctive therapy model is proposed. It can prospectively assist physicians in proposing treatment strategies, assess the patient’s risk status and treatment methods early on, and detect deterioration trends in advance.

Funder

National Natural Science Foundation of China

Publisher

IOP Publishing

Subject

Physiology (medical),Biomedical Engineering,Physiology,Biophysics

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3